Its placement on the Category 2 list was particularly controversial given its established global safety profile
doi:10.1001/jama.2009.1622 [10] Arakawa Y, Watanabe M, Inoue N, et al
Some clinicians have also raised concerns that BPC-157s influence on growth-related pathways could present a risk of tumor growth in cancerous cells
[0:18:24] The interesting thing about literally every rebuttal statement, none of them have addressed the data
doi: 10.1038/s41467-021-25855-2 138 LiuC
Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, Barford D (2003) Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate